Positive airway pressure therapy for obstructive sleep apnea in patients with Osteogenesis imperfecta: a prospective pilot study

dc.contributor.authorArponen Heidi
dc.contributor.authorBachour Adel
dc.contributor.authorBäck Leif
dc.contributor.authorValta Helena
dc.contributor.authorMäkitie Antti
dc.contributor.authorMäkitie Outi
dc.contributor.authorWaltimo-Sirén Janna
dc.contributor.organizationfi=hammaslääketieteen laitos|en=Institute of Dentistry|
dc.contributor.organization-code1.2.246.10.2458963.20.64787032594
dc.converis.publication-id52136053
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/52136053
dc.date.accessioned2022-10-27T11:53:13Z
dc.date.available2022-10-27T11:53:13Z
dc.description.abstract<p>Background<br>Obstructive sleep apnea (OSA) is prevalent in individuals with Osteogenesis imperfecta (OI). To date, no study has investigated treatment of OSA in adult individuals with OI using positive airway pressure (PAP). This observational pilot study examined the adherence of adults with OI to treatment of OSA with PAP therapy, and the evolution of self-experienced sleepiness and depression symptoms before and after treatment.</p><p>Methods<br>We included 20 patients, with a mean age of 51 years, who represented varying severity of OI and displayed an apnea and hypopnea index ≥ 5 /sleeping hour as recorded by an overnight polysomnography. PAP therapy was proposed to all patients. Epworth Sleepiness Scale (ESS) questionnaire to evaluate daytime sleepiness, and a validated self-rating depression questionnaire to identify possible depression, were completed prior to PAP therapy and repeated after a minimum of one year. The datasets supporting the conclusions of this article are included within the article.</p><p>Results<br>From the 20 patients, 15 initiated PAP therapy, and two patients later interrupted it. The mean PAP follow-up period was 1230 days. At baseline, an abnormally high ESS score was reported by 29% of the respondents, and an abnormally high number of symptoms suggesting depression by 29%. Follow-up questionnaires were completed by 60% of the patients, of whom 83% were adherent to PAP treatment. ESS score and depression symptoms did not decrease significantly with PAP therapy.</p><p>Conclusions<br>Patients with OI accepted well PAP therapy and remained compliant. Sleepiness and depression persisted unaltered despite good PAP adherence. These unexpectedly poor improvements in symptoms by PAP therapy may be due to subjective depression symptoms and the complexity of factors underlying persisting sleepiness in OI. Further research is needed to confirm this novel finding.</p>
dc.identifier.eissn1471-2474
dc.identifier.jour-issn1471-2474
dc.identifier.olddbid172559
dc.identifier.oldhandle10024/155653
dc.identifier.urihttps://www.utupub.fi/handle/11111/30399
dc.identifier.urnURN:NBN:fi-fe2021042821726
dc.language.isoen
dc.okm.affiliatedauthorWaltimo-Siren, Janna
dc.okm.discipline313 Dentistryen_GB
dc.okm.discipline313 Hammaslääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBioMed Central
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumber61
dc.relation.doi10.1186/s12891-020-03932-9
dc.relation.ispartofjournalBMC Musculoskeletal Disorders
dc.relation.issue1
dc.relation.volume22
dc.source.identifierhttps://www.utupub.fi/handle/10024/155653
dc.titlePositive airway pressure therapy for obstructive sleep apnea in patients with Osteogenesis imperfecta: a prospective pilot study
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s12891-020-03932-9.pdf
Size:
637.69 KB
Format:
Adobe Portable Document Format
Description:
Publisher´s PDF